X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3078) 3078
Publication (156) 156
Newspaper Article (54) 54
Magazine Article (40) 40
Book Review (37) 37
Book Chapter (16) 16
Newsletter (11) 11
Dissertation (5) 5
Conference Proceeding (3) 3
Trade Publication Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tacrine (1682) 1682
humans (1343) 1343
animals (1083) 1083
alzheimer's disease (947) 947
male (905) 905
alzheimer disease - drug therapy (892) 892
tacrine - pharmacology (820) 820
alzheimers-disease (754) 754
pharmacology & pharmacy (741) 741
rats (657) 657
cholinesterase inhibitors - pharmacology (620) 620
tacrine - therapeutic use (539) 539
index medicus (531) 531
female (471) 471
aged (444) 444
neurosciences (436) 436
cholinesterase inhibitors - therapeutic use (421) 421
acetylcholinesterase (401) 401
chemistry, medicinal (376) 376
dementia (344) 344
dose-response relationship, drug (339) 339
tacrine - analogs & derivatives (304) 304
acetylcholinesterase - metabolism (291) 291
donepezil (287) 287
biochemistry & molecular biology (280) 280
cholinesterase inhibitors - chemistry (279) 279
acetylcholinesterase inhibitors (271) 271
clinical neurology (269) 269
tacrine - chemistry (254) 254
tetrahydroaminoacridine (253) 253
mice (252) 252
double-blind (241) 241
middle aged (240) 240
psychiatry (231) 231
senile dementia (231) 231
drug therapy (219) 219
rats, sprague-dawley (199) 199
cholinesterase inhibitors - chemical synthesis (196) 196
structure-activity relationship (196) 196
cholinesterase inhibitors (195) 195
memory (189) 189
alzheimers disease (188) 188
brain (188) 188
derivatives (175) 175
butyrylcholinesterase (170) 170
rats, wistar (167) 167
physostigmine (166) 166
rivastigmine (165) 165
analysis (163) 163
acetylcholine (162) 162
tacrine - administration & dosage (161) 161
tacrine - adverse effects (160) 160
aged, 80 and over (159) 159
cholinesterase-inhibitors (159) 159
drugs (152) 152
alzheimer disease - psychology (151) 151
double-blind method (151) 151
chemistry, organic (149) 149
inhibitors (146) 146
in vitro techniques (142) 142
models, molecular (140) 140
molecular structure (139) 139
alzheimer’s disease (138) 138
kinetics (138) 138
acetylcholinesterase - chemistry (136) 136
controlled trial (135) 135
alzheimer disease - metabolism (131) 131
binding (130) 130
chemistry, multidisciplinary (130) 130
disease (128) 128
nootropic agents - therapeutic use (128) 128
brain - drug effects (127) 127
treatment outcome (127) 127
indans - therapeutic use (126) 126
piperidines - therapeutic use (125) 125
geriatrics & gerontology (122) 122
alzheimer disease - diagnosis (121) 121
drug design (121) 121
butyrylcholinesterase - metabolism (118) 118
biological evaluation (116) 116
oxidative stress (116) 116
physostigmine - pharmacology (115) 115
time factors (112) 112
design (110) 110
cholinesterase inhibitors - adverse effects (108) 108
memory - drug effects (108) 108
tacrine - pharmacokinetics (107) 107
clinical trials as topic (106) 106
rat (104) 104
alzheimer disease - physiopathology (103) 103
enzyme inhibitors (102) 102
medicine, general & internal (102) 102
multicenter (102) 102
cognition - drug effects (101) 101
inhibition (101) 101
neurodegenerative diseases (100) 100
in-vitro (98) 98
neurons - drug effects (98) 98
cholinesterase inhibitors - administration & dosage (97) 97
binding sites (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3013) 3013
French (41) 41
Russian (26) 26
Spanish (26) 26
Japanese (21) 21
Chinese (18) 18
German (18) 18
Czech (15) 15
Korean (8) 8
Swedish (7) 7
Portuguese (5) 5
Polish (3) 3
Dutch (2) 2
Italian (2) 2
Norwegian (2) 2
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2009, Volume 52, Issue 17, pp. 5365 - 5379
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2012, Volume 55, Issue 3, pp. 1303 - 1317
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 07/2010, Volume 53, Issue 13, pp. 4927 - 4937
Journal Article
Neuropharmacology, ISSN 0028-3908, 02/2012, Volume 62, Issue 2, pp. 997 - 1003
Journal Article
Molecules, ISSN 1420-3049, 02/2013, Volume 18, Issue 2, pp. 2397 - 2418
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 02/2017, Volume 127, pp. 250 - 262
Multi-target drug discovery is one of the most followed approaches in the active central nervous system (CNS) therapeutic area, especially in the search for... 
Neuroinflammation | Amyloid | Acetylcholinesterase | Alzheimer's disease | Multitarget compounds | DESIGN | CHEMISTRY, MEDICINAL | MULTITARGET DRUG DISCOVERY | NATURAL-PRODUCTS | NEURODEGENERATIVE DISEASES | POLYPHARMACOLOGY | BIOLOGICAL EVALUATION | AGENTS | ACETYLCHOLINESTERASE INHIBITORS | DERIVATIVES | AGGREGATION | Neuroprotective Agents - therapeutic use | Antioxidants - chemistry | Antioxidants - metabolism | Humans | Cholinesterase Inhibitors - chemistry | Stilbenes - chemistry | Molecular Targeted Therapy | Tacrine - therapeutic use | Tacrine - pharmacology | Neuroprotective Agents - pharmacology | Cholinesterase Inhibitors - metabolism | Liver - drug effects | Butyrylcholinesterase - metabolism | Drug Design | Tacrine - chemistry | Protein Aggregates - drug effects | Tacrine - metabolism | Neuroprotective Agents - chemistry | Alzheimer Disease - drug therapy | Rats | Antioxidants - pharmacology | Blood-Brain Barrier - metabolism | Antioxidants - therapeutic use | Peptide Fragments - chemistry | Animals | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Ligands | Amyloid beta-Peptides - chemistry | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Antioxidants | Analysis | Pharmacy | Resveratrol | Drugstores | Drug discovery | Permeability | Health aspects | Target marketing | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 07/2014, Volume 82, pp. 426 - 438
Journal Article
Bioorganic and Medicinal Chemistry, ISSN 0968-0896, 08/2013, Volume 21, Issue 15, pp. 4559 - 4569
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 03/2015, Volume 93, pp. 42 - 50
Combining tacrine with trolox in a single molecule, novel multifunctional hybrids have been designed and synthesized. All these hybrids showed ChE inhibitory... 
Antioxidant | Trolox | Alzheimer's disease | Hepatotoxicity | Tacrine | Cholinesterase | NO DONOR | TARGET-DIRECTED LIGANDS | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | RAT HEPATOCYTES | NEURODEGENERATIVE DISEASES | IN-VITRO | AMYLOID-BETA | ACETYLCHOLINESTERASE INHIBITORS | DERIVATIVES | Cholinesterase Inhibitors - pharmacokinetics | Male | Cholinesterase Inhibitors - chemical synthesis | PC12 Cells | Tacrine - adverse effects | Tacrine - pharmacology | Neuroprotective Agents - pharmacology | Tacrine - pharmacokinetics | Chromans - pharmacokinetics | Chromans - pharmacology | Neuroprotective Agents - pharmacokinetics | Swine | Picrates - chemistry | Drug Design | Molecular Structure | Biphenyl Compounds - chemistry | Neuroprotective Agents - adverse effects | Chromans - chemistry | Tacrine - chemistry | Cell Survival - drug effects | Chemical and Drug Induced Liver Injury - prevention & control | Alzheimer Disease - drug therapy | Rats | Alzheimer Disease - enzymology | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Blood-Brain Barrier - metabolism | Chromans - adverse effects | Neuroprotective Agents - chemical synthesis | Animals | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Cholinesterase Inhibitors - adverse effects | Antioxidants - adverse effects | Molecular Docking Simulation | Kinetics | Antioxidants - pharmacokinetics | In Vitro Techniques | Antioxidants | Enzyme inhibitors | Drug therapy | Analysis | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 01/2015, Volume 89, pp. 296 - 303
Journal Article
Bioorganic and Medicinal Chemistry, ISSN 0968-0896, 11/2014, Volume 22, Issue 21, pp. 6089 - 6104
A series of tacrine-(β-carboline) hybrids (11a-q) were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's... 
β-Amyloid aggregation | β-Carboline | Alzheimers disease | Antioxidant | Metal chelator | Tacrine | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | TACRINE HYBRIDS | RADICAL SCAVENGERS | CARBOLINE ALKALOIDS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | beta-Carboline | CHOLINESTERASE-INHIBITORS | BUTYRYLCHOLINESTERASE INHIBITORS | ANTIOXIDANT PROPERTIES | L-TRYPTOPHAN | beta-Amyloid aggregation | BIOLOGICAL EVALUATION | Alzheimer's disease | Cholinesterase Inhibitors - pharmacokinetics | Antioxidants - chemistry | Humans | Cholinesterase Inhibitors - chemistry | Carbolines - chemistry | Tacrine - pharmacology | Tacrine - pharmacokinetics | Chelating Agents - pharmacokinetics | Butyrylcholinesterase - metabolism | Amyloid beta-Peptides - metabolism | Drug Design | Tacrine - chemistry | Cell Line | Chelating Agents - chemistry | Alzheimer Disease - drug therapy | Electrophorus | Alzheimer Disease - enzymology | Antioxidants - pharmacology | Chelating Agents - pharmacology | Protein Aggregation, Pathological - drug therapy | Blood-Brain Barrier - metabolism | Animals | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Horses | Molecular Docking Simulation | Carbolines - pharmacokinetics | Antioxidants - pharmacokinetics | Acetylcholinesterase - metabolism | Protein Aggregation, Pathological - metabolism | Carbolines - pharmacology | Drug therapy | Analysis
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 08/2016, Volume 118, pp. 178 - 192
Journal Article